Collectively, these different signaling paradigms involved with EMT in ovarian cancer suggest that growth factor receptor glycosylation modification involving the receptor-signaling platform of a Neu1-MMP-9 crosstalk may in fact be the invisible link connecting the Snail-MMP-9 signaling axis. This evidence concerns the gene NEU1 and ovarian cancer.